Sinusitis in Immunocompromised, Diabetic, and Human Immunodeficiency Virus–Infected Patients

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review


Over the past several decades, medical advancements in transplantation and in the treatment of immunocompromised patients have led to increased survival in several patient populations including oncology and transplant patients, type 1 diabetics, and human immunodeficiency virus (HIV)-infected patients. Not surprisingly, these patients are at increased risk for infectious complications. As the at-risk population continues to grow, sinusitis has become an increasingly recognized problem in these immunocompromised groups and presents unique challenges to the clinician in both diagnosis and management. Although each group differs in its acquired risk and the various impairments in the immune function, the importance of early recognition, diagnosis, and aggressive combinedmodality treatment is common to all immunocompromised patients.

Original languageEnglish
Title of host publicationSinusitis
Subtitle of host publicationFrom Microbiology to Management
PublisherCRC Press
Number of pages18
ISBN (Electronic)9780849361289
ISBN (Print)9780824729486
StatePublished - 1 Jan 2005
Externally publishedYes


Dive into the research topics of 'Sinusitis in Immunocompromised, Diabetic, and Human Immunodeficiency Virus–Infected Patients'. Together they form a unique fingerprint.

Cite this